Radiotherapy and chemotherapy are two treatment methods commonly used in cancer management, but their modes of action are very different. Radiotherapy involves directing high-energy radiation towards the area where the cancerous cells are located. It is therefore regarded as a predominantly localised treatment. The tumour area is targeted with precision, whilst the surrounding healthy tissues are preserved as far as possible. It can be used notably when the tumour is confined to a specific region, to reduce it before surgery, to control any remaining cancerous cells after an operation, or in some cases as the primary treatment.
Contact Us
Chemotherapy, for its part, is a medication-based treatment that can act throughout the entire body. Chemotherapy drugs, administered intravenously, orally, or through other routes, enter the bloodstream and can reach different parts of the body. It therefore targets not only the area where the tumour is located but also cancerous cells that may have spread. Whilst radiotherapy acts primarily on a defined area, chemotherapy has a broader scope of action. This fundamental difference plays an important role in the choice of treatment, depending on the patient, the stage of the disease, and the therapeutic objective being pursued.
What Are the Main Differences in Terms of Side Effects?
The side effects of radiotherapy are most often related to the area being irradiated. For example, when radiotherapy is applied to the head and neck, it can cause dry mouth, difficulty swallowing, changes in taste, or skin sensitivity. When it involves the chest area, it may produce skin redness, fatigue, or temporary breathing discomfort. If directed at the abdomen or the pelvic region, it can lead to nausea, changes in bowel habits, loss of appetite, or certain urinary sensitivities. These effects do not manifest with the same intensity in every patient; the dose administered, the area treated, the number of sessions, and the person's general condition all directly influence the course of the treatment.
The side effects of chemotherapy tend to be felt more widely, as the drugs used circulate throughout the body. Significant fatigue, nausea, loss of appetite, hair loss, mouth sores, a drop in blood values, greater susceptibility to infections, and in some patients numbness in the hands and feet may all be observed. However, it should not be assumed that every person receiving chemotherapy experiences the same journey. The type of drug used, the dosages, the intervals between cycles, the duration of treatment, the patient's age, their immune status, and any associated conditions can all alter the nature and intensity of the side effects. Today, thanks to supportive treatments, regular blood monitoring, nutritional follow-up, and personalised treatment plans, many adverse effects can be better controlled.
Which Treatment Is Most Often Favoured?
It would not be accurate to say that one treatment is systematically preferred over the other when comparing radiotherapy and chemotherapy. In oncology, the decision does not depend on how frequently a treatment is used but on the type of cancer, its stage, the degree of spread, and the expected outcome. In certain cancers, radiotherapy may hold a more prominent place, whilst in other situations, chemotherapy may constitute the primary approach. In some cases, both methods may also be used together. Radiotherapy and chemotherapy are not always direct alternatives they can sometimes complement each other within the same treatment pathway.
For example, if the tumour is confined to a specific area and the aim is to control the disease locally, radiotherapy may become a particularly suitable option. By contrast, if the disease carries a risk of spreading through the body or if cancerous cells are thought to have reached other regions, chemotherapy can offer a more comprehensive approach. In some patients, chemotherapy may be administered at the same time as radiotherapy in order to enhance its effectiveness. It is therefore more important to ask which treatment is most appropriate for which patient, rather than seeking to determine which is used most often. The treatment plan is established taking into account both the biological behaviour of the disease and the patient's overall condition.
How Is the Choice of Treatment Determined for Each Patient?
The choice of treatment is based first and foremost on a detailed analysis of the type of cancer, its stage, the location of the tumour, and whether it has spread. Even cancers affecting the same organ do not always present the same characteristics from one patient to another. The cellular structure of the tumour, its rate of growth, its relationship with neighbouring tissues, and its likely capacity to respond to treatment all play an important role in the decision-making process. Imaging results, the biopsy report, blood tests, and the patient's general condition are assessed together. If radiotherapy is being considered, the area to be irradiated, the healthy tissues to be protected, and the dose to be delivered are calculated with precision. If chemotherapy is planned, the drugs selected are evaluated according to the patient's organ function and their overall capacity to tolerate the treatment.
The patient's age, existing conditions, immune system, level of independence in daily life, and ability to follow the treatment are also important factors. In some patients, the aim may be to treat the disease curatively, whilst in others, it may involve reducing the tumour, controlling the spread, relieving pain, or preserving quality of life. This is why the choice between radiotherapy and chemotherapy does not rest on a single model. Each patient is assessed on the basis of their own medical data, and the treatment plan is prepared on a personalised basis. The most appropriate approach is to analyse all of the findings with the relevant specialists in order to define the treatment best suited to the situation.